KEGG   DRUG: Efgartigimod alfa
Entry
D11876                      Drug                                   

Name
Efgartigimod alfa (USAN/INN);
Efgartigimod alfa (genetical recombination) (JAN)
Formula
C2310H3554N602O692S14
Exact mass
51247.7506
Mol weight
51279.464
Sequence
DKTHTCPPCP APELLGGPSV FLFPPKPKDT LYITREPEVT CVVVDVSHED PEVKFNWYVD
GVEVHNAKTK PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK
GQPREPQVYT LPPSRDELTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS
DGSFFLYSKL TVDKSRWQQG NVFSCSVMHE ALKFHYTQKS LSLSPGK
(Disulfide bridge: 6-6', 9-9', 41-101, 147-205, 41'-101', 147'-205')
  Type
Peptide
Efficacy
Autoimmune disease treatment
Comment
Treatment of IgG-driven autoimmune diseases
Target
FCGRT [HSA:2217] [KO:K24019]
Brite
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Organismal systems
   Immune system
    FCGRT
     D11876  Efgartigimod alfa (USAN/INN)
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D11876
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11876
Other DBs
CAS: 1821402-21-4
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system